Skip to main content
NCBI home page
The American Journal of Pathology logoLink to The American Journal of Pathology
. 1997 Dec;151(6):1511–1515.

Fibrous dysplasia of bone: the bone lesion unmasked.

F R Singer 1
PMCID: PMC1858358  PMID: 9403700

Full text

PDF
1511

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abate C., Curran T. Encounters with Fos and Jun on the road to AP-1. Semin Cancer Biol. 1990 Feb;1(1):19–26. [PubMed] [Google Scholar]
  2. Aoki T., Kouho H., Hisaoka M., Hashimoto H., Nakata H., Sakai A. Intramuscular myxoma with fibrous dysplasia: a report of two cases with a review of the literature. Pathol Int. 1995 Feb;45(2):165–171. doi: 10.1111/j.1440-1827.1995.tb03438.x. [DOI] [PubMed] [Google Scholar]
  3. BENEDICT P. H. Endocrine features in Albright's syndrome (fibrous dysplasia of bone). Metabolism. 1962 Jan;11:30–45. [PubMed] [Google Scholar]
  4. Benedict P. H., Szabó G., Fitzpatrick T. B., Sinesi S. J. Melanotic macules in Albright's syndrome and in neurofibromatosis. JAMA. 1968 Aug 26;205(9):618–626. [PubMed] [Google Scholar]
  5. Candeliere G. A., Glorieux F. H., Prud'homme J., St-Arnaud R. Increased expression of the c-fos proto-oncogene in bone from patients with fibrous dysplasia. N Engl J Med. 1995 Jun 8;332(23):1546–1551. doi: 10.1056/NEJM199506083322304. [DOI] [PubMed] [Google Scholar]
  6. Candeliere G. A., Roughley P. J., Glorieux F. H. Polymerase chain reaction-based technique for the selective enrichment and analysis of mosaic arg201 mutations in G alpha s from patients with fibrous dysplasia of bone. Bone. 1997 Aug;21(2):201–206. doi: 10.1016/s8756-3282(97)00107-5. [DOI] [PubMed] [Google Scholar]
  7. Chapurlat R. D., Delmas P. D., Liens D., Meunier P. J. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res. 1997 Oct;12(10):1746–1752. doi: 10.1359/jbmr.1997.12.10.1746. [DOI] [PubMed] [Google Scholar]
  8. Creagh M. F., Nunan T. O. Positive gallium-67 citrate uptake in a patient with polyostotic fibrous dysplasia. Clin Nucl Med. 1988 Apr;13(4):241–242. doi: 10.1097/00003072-198804000-00003. [DOI] [PubMed] [Google Scholar]
  9. Cuttler L., Jackson J. A., Saeed uz-Zafar M., Levitsky L. L., Mellinger R. C., Frohman L. A. Hypersecretion of growth hormone and prolactin in McCune-Albright syndrome. J Clin Endocrinol Metab. 1989 Jun;68(6):1148–1154. doi: 10.1210/jcem-68-6-1148. [DOI] [PubMed] [Google Scholar]
  10. Daffner R. H., Kirks D. R., Gehweiler J. A., Jr, Heaston D. K. Computed tomography of fibrous dysplasia. AJR Am J Roentgenol. 1982 Nov;139(5):943–948. doi: 10.2214/ajr.139.5.943. [DOI] [PubMed] [Google Scholar]
  11. Dent C. E., Gertner J. M. Hypophosphataemic osteomalacia in fibrous dysplasia. Q J Med. 1976 Jul;45(179):411–420. [PubMed] [Google Scholar]
  12. Dumont J. E., Jauniaux J. C., Roger P. P. The cyclic AMP-mediated stimulation of cell proliferation. Trends Biochem Sci. 1989 Feb;14(2):67–71. doi: 10.1016/0968-0004(89)90046-7. [DOI] [PubMed] [Google Scholar]
  13. HARRIS W. H., DUDLEY H. R., Jr, BARRY R. J. The natural history of fibrous dysplasia. An orthopaedic, pathological, and roentgenographic study. J Bone Joint Surg Am. 1962 Mar;44-A:207–233. [PubMed] [Google Scholar]
  14. Herlyn M., Mancianti M. L., Jambrosic J., Bolen J. B., Koprowski H. Regulatory factors that determine growth and phenotype of normal human melanocytes. Exp Cell Res. 1988 Dec;179(2):322–331. doi: 10.1016/0014-4827(88)90271-6. [DOI] [PubMed] [Google Scholar]
  15. Kaplan F. S., Fallon M. D., Boden S. D., Schmidt R., Senior M., Haddad J. G. Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). N Engl J Med. 1988 Aug 18;319(7):421–425. doi: 10.1056/NEJM198808183190707. [DOI] [PubMed] [Google Scholar]
  16. Liens D., Delmas P. D., Meunier P. J. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet. 1994 Apr 16;343(8903):953–954. doi: 10.1016/s0140-6736(94)90069-8. [DOI] [PubMed] [Google Scholar]
  17. Machida K., Makita K., Nishikawa J., Ohtake T., Iio M. Scintigraphic manifestation of fibrous dysplasia. Clin Nucl Med. 1986 Jun;11(6):426–429. doi: 10.1097/00003072-198606000-00015. [DOI] [PubMed] [Google Scholar]
  18. Malchoff C. D., Reardon G., MacGillivray D. C., Yamase H., Rogol A. D., Malchoff D. M. An unusual presentation of McCune-Albright syndrome confirmed by an activating mutation of the Gs alpha-subunit from a bone lesion. J Clin Endocrinol Metab. 1994 Mar;78(3):803–806. doi: 10.1210/jcem.78.3.8126161. [DOI] [PubMed] [Google Scholar]
  19. Marie P. J., de Pollak C., Chanson P., Lomri A. Increased proliferation of osteoblastic cells expressing the activating Gs alpha mutation in monostotic and polyostotic fibrous dysplasia. Am J Pathol. 1997 Mar;150(3):1059–1069. [PMC free article] [PubMed] [Google Scholar]
  20. McArthur R. G., Hayles A. B., Lambert P. W. Albright's syndrome with rickets. Mayo Clin Proc. 1979 May;54(5):313–320. [PubMed] [Google Scholar]
  21. Mills B. G., Masuoka L. S., Graham C. C., Jr, Singer F. R., Waxman A. D. Gallium-67 citrate localization in osteoclast nuclei of Paget's disease of bone. J Nucl Med. 1988 Jun;29(6):1083–1087. [PubMed] [Google Scholar]
  22. Norris M. A., Kaplan P. A., Pathria M., Greenway G. Fibrous dysplasia: magnetic resonance imaging appearance at 1.5 tesla. Clin Imaging. 1990 Aug;14(3):211–215. doi: 10.1016/0899-7071(90)90075-m. [DOI] [PubMed] [Google Scholar]
  23. Riminucci M., Fisher L. W., Shenker A., Spiegel A. M., Bianco P., Gehron Robey P. Fibrous dysplasia of bone in the McCune-Albright syndrome: abnormalities in bone formation. Am J Pathol. 1997 Dec;151(6):1587–1600. [PMC free article] [PubMed] [Google Scholar]
  24. Roodman G. D., Kurihara N., Ohsaki Y., Kukita A., Hosking D., Demulder A., Smith J. F., Singer F. R. Interleukin 6. A potential autocrine/paracrine factor in Paget's disease of bone. J Clin Invest. 1992 Jan;89(1):46–52. doi: 10.1172/JCI115584. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Ruggieri P., Sim F. H., Bond J. R., Unni K. K. Malignancies in fibrous dysplasia. Cancer. 1994 Mar 1;73(5):1411–1424. doi: 10.1002/1097-0142(19940301)73:5<1411::aid-cncr2820730516>3.0.co;2-t. [DOI] [PubMed] [Google Scholar]
  26. Sassone-Corsi P., Visvader J., Ferland L., Mellon P. L., Verma I. M. Induction of proto-oncogene fos transcription through the adenylate cyclase pathway: characterization of a cAMP-responsive element. Genes Dev. 1988 Dec;2(12A):1529–1538. doi: 10.1101/gad.2.12a.1529. [DOI] [PubMed] [Google Scholar]
  27. Schwindinger W. F., Francomano C. A., Levine M. A. Identification of a mutation in the gene encoding the alpha subunit of the stimulatory G protein of adenylyl cyclase in McCune-Albright syndrome. Proc Natl Acad Sci U S A. 1992 Jun 1;89(11):5152–5156. doi: 10.1073/pnas.89.11.5152. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Shenker A., Chanson P., Weinstein L. S., Chi P., Spiegel A. M., Lomri A., Marie P. J. Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs alpha gene. Hum Mol Genet. 1995 Sep;4(9):1675–1676. doi: 10.1093/hmg/4.9.1675. [DOI] [PubMed] [Google Scholar]
  29. Shenker A., Weinstein L. S., Moran A., Pescovitz O. H., Charest N. J., Boney C. M., Van Wyk J. J., Merino M. J., Feuillan P. P., Spiegel A. M. Severe endocrine and nonendocrine manifestations of the McCune-Albright syndrome associated with activating mutations of stimulatory G protein GS. J Pediatr. 1993 Oct;123(4):509–518. doi: 10.1016/s0022-3476(05)80943-6. [DOI] [PubMed] [Google Scholar]
  30. Shenker A., Weinstein L. S., Sweet D. E., Spiegel A. M. An activating Gs alpha mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab. 1994 Sep;79(3):750–755. doi: 10.1210/jcem.79.3.8077356. [DOI] [PubMed] [Google Scholar]
  31. Shires R., Whyte M. P., Avioli L. V. Idiopathic hypothalamic hypogonadotropic hypogonadism with polyostotic fibrous dysplasia. Arch Intern Med. 1979 Oct;139(10):1187–1189. [PubMed] [Google Scholar]
  32. Suarez H. G., du Villard J. A., Caillou B., Schlumberger M., Parmentier C., Monier R. gsp mutations in human thyroid tumours. Oncogene. 1991 Apr;6(4):677–679. [PubMed] [Google Scholar]
  33. Weinstein L. S., Shenker A., Gejman P. V., Merino M. J., Friedman E., Spiegel A. M. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med. 1991 Dec 12;325(24):1688–1695. doi: 10.1056/NEJM199112123252403. [DOI] [PubMed] [Google Scholar]
  34. Weinstein R. S. Long-term aminobisphosphonate treatment of fibrous dysplasia: spectacular increase in bone density. J Bone Miner Res. 1997 Aug;12(8):1314–1315. doi: 10.1359/jbmr.1997.12.8.1314. [DOI] [PubMed] [Google Scholar]
  35. Wu J. X., Carpenter P. M., Gresens C., Keh R., Niman H., Morris J. W., Mercola D. The proto-oncogene c-fos is over-expressed in the majority of human osteosarcomas. Oncogene. 1990 Jul;5(7):989–1000. [PubMed] [Google Scholar]
  36. Yamamoto T., Ozono K., Kasayama S., Yoh K., Hiroshima K., Takagi M., Matsumoto S., Michigami T., Yamaoka K., Kishimoto T. Increased IL-6-production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest. 1996 Jul 1;98(1):30–35. doi: 10.1172/JCI118773. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. van der Plas A., Feyen J. H., Nijweide P. J. Direct effect of parathyroid hormone on the proliferation of osteoblast-like cells; a possible involvement of cyclic AMP. Biochem Biophys Res Commun. 1985 Jun 28;129(3):918–925. doi: 10.1016/0006-291x(85)91979-5. [DOI] [PubMed] [Google Scholar]

Articles from The American Journal of Pathology are provided here courtesy of American Society for Investigative Pathology

RESOURCES